Search

Your search keyword '"Iti Varshney"' showing total 3 results
Start Over Author "Iti Varshney" Publication Year Range Last 50 years
3 results on '"Iti Varshney"'

1. Lipoid proteinosis coexisting with rare psychiatric manifestations: a case report with a review of literature

Author

Kritika Gupta, Hania Khan, Syed Amin, Iti Varshney, Saifullah Khalid, and Murad Ahmed

Subjects
lipoid proteinosis, urbach-wiethe disease, schizophrenia, Medicine, Dermatology, RL1-803
Abstract

Lipoid proteinosis is a rare autosomal recessive genodermatosis characterized by the deposition of hyaline material in the skin and internal organs. Skin involvement is in the form of blisters in infancy healing with pock-like scars, yellow waxy papules, plaques, moniliform blepharosis and diffuse infiltration. Neurological manifestations such as epilepsy, schizophrenia and memory loss have also been reported. We report the case of a 24-year-old female with lipoid proteinosis with neuro-psychiatric symptoms. Her non-contrast computed tomography of the head showed symmetrical calcification involving bilateral medial temporal lobes. We also review the literature on previous publications of lipoid proteinosis cases with neuropsychiatric involvement.

Published
2023
Full Text
View/download PDF

2. Hutchinson-Gilford progeria syndrome: a rare premature ageing syndrome

Author

Iti Varshney, Mohammad Adil, Syed Suhail Amin, Mohd Mohtashim, Annu Priya, and Mahtab Alam

Subjects
premature ageing syndrome, progeria, ageing., Medicine, Dermatology, RL1-803
Abstract

Hutchinson-Gilford progeria syndrome is an extremely rare genetic disorder characterized by premature ageing involving the skin, bones, heart, and blood vessels. The incidence is 1 in several million births. It occurs sporadically and is probably an autosomal dominant syndrome. The diagnosis is essentially clinical and the manifestations become more evident from the first year of life. We report a case of a seven-month- old boy with clinical manifestations characteristic of this syndrome. He had a characteristic “plucked-bird” appearance, prominent eyes and scalp veins, senile look, loss of scalp hair, stunted growth and mottled pigmentation with sclerodermatous changes over the trunk and lower limbs. This interesting case is reported for its rarity.

Published
2020
Full Text
View/download PDF

3. Comparative Study of Efficacy of Topical Mometasone with Calcipotriol versus Mometasone Alone in the Treatment of Alopecia Areata

Author

Fatima Tuz Zahra, Tasleem Arif, Iti Varshney, Mohammad Adil, Syed Suhail Amin, and Mahtab Alam

Subjects
medicine.medical_specialty, Vitamin D analogs, Alopecia areata, calcipotriol, Dermatology, Group B, 030207 dermatology & venereal diseases, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, medicine, skin and connective tissue diseases, Calcipotriol, integumentary system, Mometasone, business.industry, medicine.disease, Hair loss, chemistry, 030220 oncology & carcinogenesis, Etiology, Original Article, Once daily, business, medicine.drug
Abstract

Background: Alopecia areata is one of the common causes of nonscarring hair loss with autoimmune etiology. This study was designed to evaluate any added benefit of topical calcipotriol when combined with topical mometasone in the treatment of alopecia areata. To the best of our knowledge, no such study has been conducted in the past. Materials and Methods: It was a comparative analytical study done over 100 patients of clinically diagnosed alopecia areata. Group A patients (n = 50) were advised to apply topical mometasone 0.1% cream along with topical calcipotriol 0.005% ointment each once daily, whereas patients of Group B (n = 50) were advised to apply only topical mometasone 0.1% cream in the same amount, once a day. Follow-up of all patients was done at 6, 12, and 24 weeks, and the outcome was assessed according to the Severity of Alopecia Tool (SALT) score at every visit. Results: Both the groups were statistically comparable in terms of age (P = 0.694) and sex (P = 0.683) distribution. Baseline mean SALT score of Group A and Group B patients was 7.22 and 6.05, respectively (P = 0.145). At the end of 24 weeks, mean SALT score of Group A and Group B patients decreased by 4.24 and 3.39, respectively (P < 0.001). We also found that there was a significant decrease (P < 0.001) in mean SALT score at 24 weeks in patients of both groups when compared with baseline values. Conclusion: We found that adding topical calcipotriol 0.005% ointment with topical mometasone 0.1% cream has higher efficacy than topical mometasone alone, in the treatment of alopecia areata.

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results